Status:
RECRUITING
Evaluation of Valvular Heart Disease Using Cardiac CT
Lead Sponsor:
Toho University
Conditions:
Valvular Heart Disease
Eligibility:
All Genders
18+ years
Brief Summary
The EVIDENTIA Registry is a multicenter study designed to evaluate valvular heart disease (VHD) using cardiac CT. It aims to assess cardiac valve anatomy, function, and myocardial characteristics thro...
Eligibility Criteria
Inclusion
- Patients with at least moderate valvular heart disease who had a cardiac CT with 64 or more rows
- 18 years of age or older
Exclusion
- Less than 18 years old
- Acute VHD
- Infectious endocarditis
- Patients with post-VHD intervention
- Poor CT image quality for analyzing CT data.
Key Trial Info
Start Date :
March 12 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2028
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT06937125
Start Date
March 12 2025
End Date
March 1 2028
Last Update
May 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toho University
Ōta-ku, Tokyo, Japan, 143-8540